Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Gee

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 3, 2025
Diabetes Educators: Understanding the Role of Finerenone in Chronic Kidney Disease Associated with Type 2 Diabetes MellitusAnne M Komé, Anita Yang, Patrick Gee, et al.
Advances in Therapy|October 25, 2022
Living with Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Patient and Clinician PerspectiveSusanne B Nicholas, Eugene E Wright, Liana K Billings, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 15, 2018
Exploring Barriers and Potential Solutions in Home Dialysis: An NKF-KDOQI Conference Outcomes ReportChristopher T Chan, Eric Wallace, Thomas A Golper, et al.
Research Involvement and Engagement|June 17, 2025
The ultimate power play in research - partnering with patients, partnering with powerDawn P Richards, Janelle Bowden, Patrick Gee, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 1, 2025
A Systematic Literature Review of Coordinated Care in Cardiovascular-Kidney-Metabolic ConditionsO Kenrik Duru, Radica Alicic, Muthiah Vaduganathan, et al.
Journal of the American College of Clinical Pharmacy : JACCP|April 20, 2026
A Scoping Review of Pharmacist-Based Interprofessional Interventions for Management of Cardiovascular-Kidney-Metabolic ConditionsWendy L St Peter, Joshua J Neumiller, Radica Alicic, et al.
Diabetes Care|June 1, 2026
Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With DiabetesYoko Narasaki, Kamyar Kalantar-Zadeh, Yaara Zisman-Ilani, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guidelineSheyu Li, Per Olav Vandvik, Lyubov Lytvyn, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 4, 2025
Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney DiseaseJ Bradley Layton, Ryan Ziemiecki, Catherine B Johannes, et al.
American Heart Journal|June 20, 2026
Lessons Learned from the Feasibility Phase of the REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) Trial ProgramMario Gaudino, Gregg W Stone, John Puskas, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 3, 2025
Diabetes Educators: Understanding the Role of Finerenone in Chronic Kidney Disease Associated with Type 2 Diabetes MellitusAnne M Komé, Anita Yang, Patrick Gee, et al.
Advances in Therapy|October 25, 2022
Living with Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Patient and Clinician PerspectiveSusanne B Nicholas, Eugene E Wright, Liana K Billings, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 15, 2018
Exploring Barriers and Potential Solutions in Home Dialysis: An NKF-KDOQI Conference Outcomes ReportChristopher T Chan, Eric Wallace, Thomas A Golper, et al.
Research Involvement and Engagement|June 17, 2025
The ultimate power play in research - partnering with patients, partnering with powerDawn P Richards, Janelle Bowden, Patrick Gee, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 1, 2025
A Systematic Literature Review of Coordinated Care in Cardiovascular-Kidney-Metabolic ConditionsO Kenrik Duru, Radica Alicic, Muthiah Vaduganathan, et al.
Journal of the American College of Clinical Pharmacy : JACCP|April 20, 2026
A Scoping Review of Pharmacist-Based Interprofessional Interventions for Management of Cardiovascular-Kidney-Metabolic ConditionsWendy L St Peter, Joshua J Neumiller, Radica Alicic, et al.
Diabetes Care|June 1, 2026
Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With DiabetesYoko Narasaki, Kamyar Kalantar-Zadeh, Yaara Zisman-Ilani, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guidelineSheyu Li, Per Olav Vandvik, Lyubov Lytvyn, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 4, 2025
Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney DiseaseJ Bradley Layton, Ryan Ziemiecki, Catherine B Johannes, et al.
American Heart Journal|June 20, 2026
Lessons Learned from the Feasibility Phase of the REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) Trial ProgramMario Gaudino, Gregg W Stone, John Puskas, et al.
Pageof 2